← All stories
● Covered by 1 source · 3 reportsMedium impact2 negative1 neutral

CDC Reportedly Plans to Fund Suspended, "Unethical" Newborn Vaccine Trial in Guinea-Bissau

🔄 Updated 30d ago — new reporting from Ars Technica
New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • CDC director's office reportedly set aside $1.6M for suspended trial.
  • Trial exposes Guinea-Bissau newborns to hepatitis B, risking lifelong infection.
  • Danish researchers leading the trial face misconduct allegations.
  • Funding would be diverted from global health security programs.
  • Police in Guinea-Bissau raided Danish researchers' offices and seized hepatitis B vaccine doses.
  • Robert F. Kennedy Jr. attempted to fund the trial with US taxpayer dollars.
  • The CDC awarded the $1.6 million grant to Peter Aaby and Christine Stabell Benn of Bandim Health Project.
  • Aaby and Stabell Benn are controversial vaccine researchers who claim vaccines cause overlooked harms.
  • Plans for the trial were halted in January due to widespread condemnation.
  • A Rolling Stone story earlier this month caused renewed outrage.
  • Guinea-Bissau's Council of Ministers formally rejected the trial.
  • Christine Stabell Benn confirmed the rejection on October 16.
  • Police raid occurred after the trial was rejected.

CDC Moves to Fund Controversial Trial

The Centers for Disease Control and Prevention (CDC) is reportedly moving to fund a hepatitis B vaccine trial in Guinea-Bissau that was previously suspended due to ethical concerns. According to a report by Rolling Stone, staff from the CDC director’s office instructed the agency’s budget office in late September to allocate $1.6 million for the trial. This decision has sparked renewed outrage among health experts.

Ethical Concerns and Suspension

The trial, designed to expose newborns in Guinea-Bissau to hepatitis B, was suspended in January following international outcry over its unethical design. Critics argue that exposing infants to the virus puts them at high risk of lifelong infection, which can lead to severe health issues like liver cirrhosis, liver cancer, and premature death. Officials in Guinea-Bissau had stated that ethical and technical reviews were ongoing and that coordination was insufficient to proceed.

Researchers Under Investigation

The proposed trial would be run by Danish researchers Christine Stabell Benn and Peter Aaby from the University of Southern Denmark. This couple has previously produced studies promoted by anti-vaccine advocates and is currently under investigation by Danish authorities for allegations of “falsification” and “scientific misconduct” related to prior vaccine research. The CDC had awarded an unsolicited grant of $1.6 million to their research group in December.

Impact on Global Health Funding

The $1.6 million designated for this trial would be drawn from the CDC’s global health security programs. These funds might otherwise be used for critical efforts, such as combating ongoing outbreaks like the Ebola epidemic in the Democratic Republic of the Congo. The Department of Health and Human Services, which oversees the CDC, has not commented on the matter.

Updates

🕒 2026-10-22 · new reporting from Ars Technica
  • Guinea-Bissau's Council of Ministers formally rejected the trial.
  • Christine Stabell Benn confirmed the rejection on October 16.
  • Police raid occurred after the trial was rejected.
🕒 2026-10-21 · new reporting from Ars Technica
  • Police in Guinea-Bissau raided Danish researchers' offices and seized hepatitis B vaccine doses.
  • Robert F. Kennedy Jr. attempted to fund the trial with US taxpayer dollars.
  • The CDC awarded the $1.6 million grant to Peter Aaby and Christine Stabell Benn of Bandim Health Project.
  • Aaby and Stabell Benn are controversial vaccine researchers who claim vaccines cause overlooked harms.
  • Plans for the trial were halted in January due to widespread condemnation.
  • A Rolling Stone story earlier this month caused renewed outrage.

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~4 min · 3 stories · Nov 21

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

How outlets covered it

Guinea-Bissau's Council of Ministers formally rejected a clinical trial funded by the US and led by Danish researchers that aimed to study alleged nonspecific harms of the newborn hepatitis B vaccine dose. The trial was widely criticized by the WHO and other experts for ethical concerns, as it would have withheld the vaccine from half of the participants, potentially exposing them to lifelong infection.

Police in Guinea-Bissau raided the offices of Danish researchers and seized hepatitis B vaccine doses intended for a newborn vaccine trial. The trial, which international health experts deemed unethical, was reportedly funded by the US Centers for Disease Control and Prevention (CDC) under Robert F. Kennedy Jr.'s influence, despite ongoing investigations into the researchers for scientific misconduct.

The CDC's director's office reportedly instructed its budget office to allocate $1.6 million for a suspended hepatitis B vaccine trial in Guinea-Bissau, despite international condemnation over its ethical design. This trial, which would expose newborns to the virus, was halted in January and is led by Danish researchers facing misconduct allegations, raising concerns about the CDC's judgment and resource allocation.